Sustained improvement in drug documentation, compliance, and disease control. A four-year analysis of an ambulatory care model.
about
Deterioration of blood pressure control after discontinuation of a physician-pharmacist collaborative interventionClinical pharmacy in disease-specific clinics.COACH trial: a randomized controlled trial of nurse practitioner/community health worker cardiovascular disease risk reduction in urban community health centers: rationale and design.How pharmacists can assist physicians with controlling blood pressure.Improving communication skills of pharmacy students through effective precepting.Evaluation of pharmacy students' blood pressure and heart rate measurement skills after completion of a patient assessment coursePharmacist-provided anticoagulation management in United States hospitals: death rates, length of stay, Medicare charges, bleeding complications, and transfusions.A cluster randomized trial to evaluate physician/pharmacist collaboration to improve blood pressure control.Management of hypertension in elderly long-term care residentsThe Team Education and Adherence Monitoring (TEAM) trial: pharmacy interventions to improve hypertension control in blacks.Clinical pharmacist staffing in United States hospitals.Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: the IMPROVE study. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers.Types of interventions made by clinical pharmacists in the IMPROVE study. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers.Report of the AACP Educating Clinical Scientists Task Force II.Group-Based Trajectory Models: Assessing Adherence to Antihypertensive Medication in Older Adults in a Community Pharmacy Setting.Clinical pharmacy services, pharmacy staffing, and hospital mortality rates.
P2860
Q33899634-B2EB35D8-A39D-4B22-9B4F-E74EBAAD90C9Q34061807-7C3B5EE9-3953-40E6-AEFA-7A87032C7B41Q34756895-8343C001-F2FE-493A-8953-BE719544BB89Q35056211-C76310E1-B8E1-45AB-81D4-FA3F3A948AA7Q35131987-4B2CC69A-D1F0-4E2C-8917-789B4F37F26CQ35741438-F826AF3D-9815-4740-A226-B7B24363B690Q35875442-0F720600-7C2F-445A-88E1-EC539DCB32E4Q36755264-31B9DC96-A0C8-4BAE-9E86-D19C23CD1A32Q37098520-9E1F5BE0-CD41-4EE3-A06C-FB4E8F98540EQ37454781-C89BCFC8-CA47-4C77-BFB4-3F77E337E9CBQ40621719-7485A8C8-8CB6-4EAD-8025-637840A4A58BQ45334438-64DBF4C8-C1AD-4B3E-87B7-F13F40D8C1B2Q45334616-347B6C79-64FE-49D5-AC10-50A7E0B1BD66Q46067224-A8ECF04C-CA91-44A9-986E-8591894EF21EQ48029889-4291B840-9308-4705-BDE6-F9A0F55B12BDQ50801305-466C7EA4-84F4-401A-B8B2-61D2D6A7A44D
P2860
Sustained improvement in drug documentation, compliance, and disease control. A four-year analysis of an ambulatory care model.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
Sustained improvement in drug ...... s of an ambulatory care model.
@en
type
label
Sustained improvement in drug ...... s of an ambulatory care model.
@en
prefLabel
Sustained improvement in drug ...... s of an ambulatory care model.
@en
P1476
Sustained improvement in drug ...... s of an ambulatory care model.
@en
P2093
P304
P356
10.1001/ARCHINTE.144.6.1159
P407
P577
1984-06-01T00:00:00Z